Platform Architecture: Stimuli-Responsive Hybrid Transport Particles — Corrected Technical White Paper

This corrected technical white paper replaces and supersedes the earlier Aurora Synapse Therapeutics Limited Vimana white paper associated with doi:10.5281/zenodo.18487909. It preserves the original document’s purpose and general structure while correcting overconfident or technically unsafe claims concerning magnetite/SPION calcination, ultrasound-triggered release mechanisms, phyllosilicate thermal shielding, gastrointestinal magnetic retention, safety language, and regulatory interpretation. The corrected v2 document reclassifies the Vimana architecture as a conceptual, hypothesis-generating inorganic carrier framework rather than a validated therapeutic platform. It states that superparamagnetic iron oxide modules should be introduced post-calcination or through a validated low-temperature route; that ultrasound-responsive release should be interpreted primarily through cavitation, acoustic streaming, shear, radiation force, permeability effects, and thermal controls unless piezoelectric causality is experimentally demonstrated; and that mica/phyllosilicate layers should be treated as moisture, surface-interaction, and mass-transfer modifiers rather than proven nanoscale thermal insulation. This is a self-published educational and conceptual materials-engineering document. It is not peer-reviewed, not a clinical protocol, not regulatory advice, not a manufacturing instruction for human administration, and not evidence that any proposed carrier is safe or effective.Additional safety note: Because intact SBA-15 or related mesoporous silica carriers may exceed the size range normally associated with rapid renal filtration, renal clearance should not be assumed. Biodistribution, degradation, renal and hepatobiliary excretion, organ-burden, and repeat-dose toxicology studies are required before any safety or clearance claim.